NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 10/13/21

Gainers: Jasper (NASDAQ:JSPR) +127%. Waitr Holdings (NASDAQ:WTRH) +55%. Clarus Therapeutics Holdings (NASDAQ:CRXT) +46%. Sono-Tek (NASDAQ:SOTK) +26%. Paltalk (NASDAQ:PALT) +21%. Statera Biopharma (NASDAQ:STAB) +20%. SMART Global Holdings (NASDAQ:SGH) +15%. NeuroBo Pharmaceuticals (NASDAQ:NRBO...

NeuroBo Pharmaceuticals (NASDAQ:NRBO) +23% announces positive recommendation from independent data safety monitoring committee of phase 2/3 clinical trial of ANA001 in hospitalized patients with moderate to severe COVID-19 Jasper Therapeutics (NASDAQ:JSPR) +22% after bullish ca...

NeuroBo Pharmaceuticals Announces Positive Recommendation from Independent Data Safety Monitoring Committee of Phase 2/3 Clinical Trial of ANA001 in Hospitalized Patients with Moderate to Severe COVID-19 Committee Advises Continuation of Trial Without Modification PR Newswir...

NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering PR Newswire BOSTON , Oct. 5, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal, ...

Xenon Pharmaceuticals XENE +90% on positive XEN1101 data in mid-stage focal epilepsy study Elmira Savings Bank ESBK +66% Community Bank System to buy Elmira Savings Bank in $82.8M all cash deal OpGen OPGN +30% after announcing preliminary Q3 revenue ahead of expe...

Gainers: Progenity (NASDAQ:PROG) +29%, Biomerica (NASDAQ:BMRA) +28%, Atea Pharmaceuticals (NASDAQ:AVIR) +19%, Silverback Therapeutics (NASDAQ:SBTX) +13%, Codexis (NASDAQ:CDXS) +12%. Losers: Omeros (NASDAQ:OMER) -41%, Adagio Therapeut...

Tarena International (NASDAQ:TEDU) -20% after delivers notice of intent to terminate merger agreement due to breach by parent and merger sub Spire Global (NYSE:SPIR) -19%. IronNet (NYSE:IRNT) -14%. Vir Biotechnology (NASDAQ:VIR) -13%. Superior Drilling Products (NYSE:SDPI) -12%. Aer...

NeuroBo Pharmaceuticals Announces $14 Million Registered Direct Offering PR Newswire BOSTON , Oct. 1, 2021 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimod...

Sonoma Pharmaceuticals (NASDAQ:SNOA) +70% on product launch in U.S. and Europe Planet Green (NYSE:PLAG) +30%. ZIVO Bioscience (NASDAQ:ZIVO) +20%. Frequency Electronics (NASDAQ:FEIM) +17% wins contract from the Office of Naval Research for atomic clock development AGM Group...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the term “technology” often brings to mind the broader digitalization movement, tech actually has the most potential in healthcare. Thanks to groundbreaking innovations, we now know much more about the h...